About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Dermatomyositis and Polymyositis Registry | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNCT01637064

Dermatomyositis and Polymyositis Registry

By creating a registry, physicians will have the opportunity to understand the clinical outcomes of Myositis patients treated with Acthar. Despite the availability of clinical exams, muscle biopsies, ...

Lead sponsor: Phoenix Neurological Associates, LTD•5 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Phoenix Neurological Associates, LTD

Retrospective and prospective data will be collected from physicians who have prescribed Acthar to myositis patients to determine what specific characteristics each patient has based on biopsy analysis, laboratory results, and clinical exams. Through biopsy analysis, subcategories of IIM will be determined and could illustrate which of these IIMs may be more responsive to Acthar therapy.

Age

18 - 85 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Age 18-85
•2. Male or Female
•3. Clinical or pathologic diagnosis of polymyositis or dermatomyositis
•4. Capable of providing informed consent and complying with treatment regimen

Exclusion Criteria

•1. History of scleroderma, osteoporosis, systemic fungal infections, ocular herpes simplex
•2. Recent surgery, history of or the presence of a peptic ulcer, congestive heart failure, uncontrolled hypertension, or sensitivity to proteins of porcine origin
•3. Any other co-morbid condition which would make completion of the trial unlikely
•4. If female, pregnant or breast-feeding; or, if of childbearing age, an unwillingness to use appropriate birth control

Related studies

Adult and Juvenile Myositis

NCT00017914 · Dermatomyositis, Polymyositis, and more

RECRUITINGPhase 1/2

Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders

NCT07089121 · Childhood-onset Systemic Lupus Erythematous, ANCA-Associated Vasculitis (AAV), and more

Rheumatology Patient Registry and Biorepository

NCT04402086 · Rheumatic Diseases, Adult Onset Still Disease, and more

RECRUITINGPhase 2/3

Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM)

NCT07160205 · Idiopathic Inflammatory Myositis (IIM), DERMATOMYOSITIS OR POLYMYOSITIS

MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)

NCT07374107 · IBM, IIM, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 6, 2015Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment100

Start dateApr 2013

Last updatedNov 6, 2015

Condition

Dermatomyositis Polymyositis

Locations shown

PNA Center for Neurological Research

Phoenix, Arizona

Ara Dikranian MD

San Diego, California

Neurology INC

Columbia, Missouri

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 6, 2015Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions